This study reveals that heme-copper-amyloid beta complexes catalyze dopamine oxidation far more efficiently than copper-amyloid beta alone, through a self-sustaining redox cycle that generates harmful hydrogen peroxide and reactive oxygen species. The research identifies Arg5 as a critical control point in this toxic cascade. The findings directly implicate A-beta’s role in disrupting dopamine homeostasis and neuronal damage in Alzheimer’s disease—a mechanism that compounds like GHK-Cu may help counteract by modulating copper-peptide interactions and oxidative stress pathways.
For your business
Heme-copper-Aβ complexes accelerate dopamine oxidation; GHK-Cu may modulate copper-peptide redox activity worth noting in neuroprotective conversations.